Edition:
United States

Neurosearch A/S (NEUR.CO)

NEUR.CO on Copenhagen Stock Exchange

3.52DKK
24 Feb 2017
Change (% chg)

kr.-0.25 (-6.63%)
Prev Close
kr.3.77
Open
kr.3.69
Day's High
kr.3.87
Day's Low
kr.3.41
Volume
284,418
Avg. Vol
130,876
52-wk High
kr.4.49
52-wk Low
kr.2.20

NEUR.CO

Chart for NEUR.CO

About

Neurosearch A/S (NEUR) is Denmark-based biopharmaceutical company. It specializes in the research, development and sale of drug candidates. The Company’s portfolio comprises three products: Tesofensine, a drug used in obesity, which works as a monoamine reuptake inhibitor (MRI); Seridopidine, which is applied in central nervous... (more)
No analyst recommendations are available for NEUR.CO.

Overall

Beta: 1.43
Market Cap(Mil.): kr.86.43
Shares Outstanding(Mil.): 24.55
Dividend: --
Yield (%): --

Financials

  NEUR.CO Industry Sector
P/E (TTM): -- 44.08 29.63
EPS (TTM): -0.22 -- --
ROI: -7.49 -3.35 12.96
ROE: -7.49 5.80 14.11

BRIEF-Neurosearch FY operating loss flat at DKK 6.3 million

* Fy operating loss 6.3 million Danish crowns ($897,550.97) versus loss 6.5 million crowns year ago

Feb 24 2017

BRIEF-NeuroSearch announces main components of resolution plan

* Sets resolution plan after Danish Supreme Court found co guilty of market manipulation based on events occurring in H1 2010

Nov 22 2016

BRIEF-Neurosearch to pay a fine of DKK 5 million

* The Danish Supreme Court today upheld Eastern High Court's decision according to which the company had been found guilty of market manipulation

Nov 14 2016

BRIEF-Neurosearch H1 operating loss narrows to DKK 1.4 million

* H1 operating loss 1.4 million Danish crowns versus loss 3.0 million crowns year ago

Aug 31 2016

More From Around the Web

Earnings vs. Estimates